Versant Capital Management, Inc Incyte Corp Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Incyte Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 303 shares of INCY stock, worth $20,382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
303
Previous 187
62.03%
Holding current value
$20,382
Previous $11,000
81.82%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding INCY
# of Institutions
697Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.07 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.44 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$675 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...